Use of chymase inhibitors for the treatment of endometriosis, post operative fibrosis and diseases which are characterized by fibrosis formation
US-11266646-B2 · Mar 8, 2022 · US
Zollner Thomas is listed as an inventor on 4 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Zollner Thomas |
| Total patents | 4 |
| First publication | May 24, 2018 |
| Latest publication | Mar 8, 2022 |
Publications ranked by popularity score, then publication date.
US-11266646-B2 · Mar 8, 2022 · US
US-2019381040-A1 · Dec 19, 2019 · US
US-RE47047-E · Sep 18, 2018 · US
US-2018143414-A1 · May 24, 2018 · US
Latest publications not already listed above.
No data yet.
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Bayer Pharma AG | 2 |
| Osram Opto Semiconductors Gmbh | 1 |
| Astrazeneca Ab | 1 |
| Bayer Ip Gmbh | 1 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P41/00 | 2 |
| A61P5/30 | 2 |
| A61P15/00 | 2 |
| A61P15/02 | 2 |
| A61K31/506 | 2 |